Standout Papers
Citation Impact
Citing Papers
Bacterial Persistence as a Phenotypic Switch
2004 StandoutScience
Trained immunity: A program of innate immune memory in health and disease
2016 StandoutScience
Immune Control of Tuberculosis by IFN-γ-Inducible LRG-47
2003 StandoutScience
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
2004 StandoutScience
Adherence to HAART Regimens
2003
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
2001 Standout
Why Don't Physicians Follow Clinical Practice Guidelines?
1999 Standout
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2013 Standout
The Tuberculin Skin Test
1993 Standout
Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness
2006
Tuberculosis: a problem with persistence
2003
An Outbreak of Tuberculosis with Accelerated Progression among Persons Infected with the Human Immunodeficiency Virus
1992 Standout
Nature, Nurture, or Chance: Stochastic Gene Expression and Its Consequences
2008 Standout
Mycobacteria other than tuberculosis. Pulmonary involvement in patients with acquired immunodeficiency syndrome
1988
Pyogenic, tuberculous, and brucellar vertebral osteomyelitis: a descriptive and comparative study of 219 cases
1997
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies
2009 Standout
Drug-Induced Hepatotoxicity
2003 Standout
Inflammatory Bowel Disease
2009 Standout
Impact of Tuberculosis Control Measures and Crowding on the Incidence of Tuberculous Infection in Maryland Prisons
1997 Standout
Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study
1994
Tuberculosis in Patients with Human Immunodeficiency Virus Infection
1999 Standout
Risk of lymphoma and leukaemia after bacille Calmette-Guérin and smallpox vaccination: A Danish case-cohort study
2009
ATP-Induced Killing of Mycobacteria by Human Macrophages Is Mediated by Purinergic P2Z(P2X7) Receptors
1997
Infliximab Maintenance Therapy for Fistulizing Crohn's Disease
2004 Standout
Ocular tuberculosis
1993
Anti-tuberculous therapy and acute liver failure
1995
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
2002 Standout
Infections in Patients with Diabetes Mellitus
1999 Standout
The challenge of emerging and re-emerging infectious diseases
2004 StandoutNature
Superspreading and the effect of individual variation on disease emergence
2005 StandoutNature
Hepatotoxicity Associated With Isoniazid Preventive Therapy
1999
Vertebral Osteomyelitis
2010 Standout
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
2000 Standout
The Pathophysiology and Treatment of Sepsis
2003 Standout
Actual Causes of Death in the United States, 2000
2004 Standout
The global situation of MDR-TB
2003
Autophagy Is a Defense Mechanism Inhibiting BCG and Mycobacterium tuberculosis Survival in Infected Macrophages
2004 Standout
Requirements for high impact diagnostics in the developing world
2006 StandoutNature
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Points of control in inflammation
2002 StandoutNature
Infection in Solid-Organ Transplant Recipients
2007 Standout
A plastid organelle as a drug target in apicomplexan parasites
1997 StandoutNature
Baylis–Hillman Reaction: Convenient Ascending Syntheses and Biological Evaluation of Acyclic Deoxy Monosaccharides as Potential Antimycobacterial Agents
2002
Substituted 4-methylquinolines as a new class of anti-tuberculosis agents
2003
Extensive Transmission ofMycobacterium tuberculosisfrom a Child
1999
Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase
2000 StandoutNature
Comparison of a Whole-Blood Interferon γ Assay With Tuberculin Skin Testing for Detecting Latent <EMPH TYPE="ITAL">Mycobacterium tuberculosis</EMPH> Infection
2001
A Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Virus Infection
1989 Standout
The Growing Burden of Tuberculosis
2003 Standout
Adherence to Medication
2005 Standout
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
The Epidemiology of Disseminated Nontuberculous Mycobacterial Infection in the Acquired Immunodeficiency Syndrome (AIDS)
1989
Click Chemistry for Drug Development and Diverse Chemical–Biology Applications
2013 Standout
Sulfatase-activated fluorophores for rapid discrimination of mycobacterial species and strains
2013 StandoutNobel
Tuberculosis, Atypical Mycobacteriosis, and the Acquired Immunodeficiency Syndrome Among Haitian and Non-Haitian Patients in South Florida
1984
Sequestration From Immune CD4 + T Cells of Mycobacteria Growing in Human Macrophages
1993 StandoutScienceNobel
Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis
1996
Inhibition of Ca2+ Signaling by Mycobacterium tuberculosisIs Associated with Reduced Phagosome–Lysosome Fusion and Increased Survival within Human Macrophages
2000
Determination of in vitro susceptibility of Mycobacterium avium complex isolates to antimycobacterial agents by various methods
1987
Prevention of Infection Due toPneumocystisspp. in Human Immunodeficiency Virus-Negative Immunocompromised Patients
2004
Recent Advances in the Management of AIDS-related Opportunistic Infections
1994
Erasing the World's Slow Stain: Strategies to Beat Multidrug-Resistant Tuberculosis
2002 Science
1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults
1993 Standout
Treatment of tuberculosis. The Mitchell lecture 1979.
1980
Efficacy of BCG Vaccine in the Prevention of Tuberculosis
1994 Standout
Diagnosis of childhood pneumonia in the tropics
2000
Family physicians managing tuberculosis. Qualitative study of overcoming barriers.
1997
Diagnosis of childhood pneumonia in the tropics
2000
Tuberculosis: Commentary on a Reemergent Killer
1992 StandoutScience
Tuberculosis in Non-Haitian Patients with Acquired Immunodeficiency Syndrome
1986
Role of CD40 Ligand inMycobacterium aviumInfection
1999
Infections due to non-tuberculous mycobacteria (NTM).
2004
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
2015 Standout
Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis
2000
Global cancer statistics, 2012
2015 Standout
Pulmonary complications of diabetes mellitus. Pneumonia.
1995
Acute Modulation of Mycobacterial Cell Envelope Biogenesis by Front‐Line Tuberculosis Drugs
2018 StandoutNobel
A new evolutionary scenario for the Mycobacterium tuberculosis complex
2002 Standout
Conducting Meta-Analyses inRwith themetaforPackage
2010 Standout
Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes
2012 Standout
Recent Advances in the Baylis−Hillman Reaction and Applications
2003 Standout
Mycobacterium aviumComplex Infection in the Acquired Immunodeficiency Syndrome
1991 Standout
The Significance of the Tuberculin Skin Test in Elderly Persons
1987 Standout
PULMONARY COMPLICATIONS OF DIABETES MELLITUS
1995
Characterization of the Mycobacterium tuberculosis iniBAC Promoter, a Promoter That Responds to Cell Wall Biosynthesis Inhibition
2000
Works of Dixie E. Snider being referenced
U.S. Public Health Service Cooperative trial of three rifampin-isoniazid regimens in treatment of pulmonary tuberculosis.
1979
The Neglected Global Tuberculosis Problem: A Report of the 1992 World Congress on Tuberculosis
1994
A Continuing Survey of Primary Drug Resistance in Tuberculosis, 1961 to 1968
2015
The booster phenomenon in serial tuberculin testing.
1979 Standout
Isoniazid-associated Hepatitis Deaths: A Review of Available Information
1992
EPIDEMIOLOGY OF TUBERCULOSIS IN THE UNITED STATES
1989
Boosting of tuberculin sensitivity among Southeast Asian refugees.
1994
Tuberculosis in children
1988
Extrapulmonary Tuberculosis in the United States
1990
Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention.
1994
The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey.
1987
Infection and disease among contacts of tuberculosis cases with drug-resistant and drug-susceptible bacilli.
1985
Supervised six-months treatment of newly diagnosed pulmonary tuberculosis using isoniazid, rifampin, and pyrazinamide with and without streptomycin.
1984
Efficacy of BCG Vaccination in Prevention of Cancer: An Update: Brief Communication 2
1978
Rapid radiometric methods to detect and differentiate Mycobacterium tuberculosis/M. bovis from other mycobacterial species.
1984
The Epidemiology of Tuberculosis in the United States
1989
A continuing survey of tuberculosis primary drug resistance in the United States: March 1975 to November 1977. A United States Public Health Service cooperative study.
1978
Tuberculosis in Patients with Human Immunodeficiency Virus Infection
1991
Guidelines for Preventing the Transmission of Tuberculosis in Health-Care Settings, with Special Focus on HIV-Related Issues
1990 Standout
Enhancing Patient Compliance with Tuberculosis Therapy
1989
A continuing survey of primary drug resistance in tuberculosis, 1961 to 1968. A U.S. Public Health Service cooperative study.
1976
Tuberculosis in the 1980s
1980
Global Epidemiology of Tuberculosis
1996
Bacille Calmette-Guérin Vaccinations and Tuberculin Skin Tests
1985
The Prevalence of Tuberculosis and Drug Resistance among Haitians
1982
Isolation of Nontuberculous Mycobacteria in the United States, 1980
1982
Tuberculosis in Correctional Institutions
1989
Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies.
1979